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Abstract: Oral controlled drug delivery has gathered tremendous attention over the years due to its many 
advantages over conventional dosage forms. Polymer-based matrices have become an integral part of the 
pharmaceutical industry. Hydrophilic matrices are capable of controlling the release of drug over an extended period 
of time. Hydrophilic polymers, especially the hydrophilic derivatives of cellulose ethers, are frequently used for 
these applications. Therefore, the objective of this review is to discuss the scientific and physicochemical aspects of 
these polymeric systems that can affect the drug release from such formulations.  
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1. Introduction 
The goal of any drug delivery system is to provide a 
therapeutic amount of drug to its intended site in the body, 
so that a desired drug concentration at the site of action is 
achieved promptly and then maintained over a specified 
period of time. Thus, an ideal drug delivery system should 
have the capacity to deliver drugs at a particular rate as 
required by the patient. However, most traditional oral 
dosage forms require frequent and repeated doses to 
achieve these objectives [1,2]. Thus, it is far from an ideal 
therapeutic environment as fluctuation of plasma drug 
concentrations over successive administrations may lead 
to overdosing or underdosing of the patient. Moreover, 
drugs with short biological half-lives require frequent 
doses to maintain therapeutic concentrations in the body. 
Additionally, the lack of compliance due to a forgotten 
dose or overnight troughs can significantly deteriorate the 
treatment plan [3]. 
Owing to these problems, controlled drug release 
approaches have become popular over the years. The use 
of hydrophilic polymers to develop hydrophilic matrices 
became eminent as they enable the drugs to be released 
continuously over long periods of time, which ultimately 
improves patient compliance and decreases patient-to -
patient variations in drug administration patterns. 
Furthermore, it reduces the total amount of administered 
drug and possible side-effects related to high peak plasma 
drug levels [4]. 
2. Hydrophilic matrices 
Hydrophilic matrix tablets are the most frequently used 
controlled release oral dosage forms intended for oral 
administration [5,6]. Commonly, hydrophilic matrices are 
compressed matrix tablets and can easily be prepared by 
direct compression of a powder mixture of drug with a 
release retardant, swellable polymer and other additives to 
aid processing. Such matrices are commonly employed 
because of the advantages associated with their 
manufacturing, including simple formulation, the use of 
existing tableting technologies and the low cost of 
polymers, which are generally regarded as safe excipients  
[7]. These hydrophilic matrices have the ability to release 
the drug over a defined period of time, as they do not 
undergo disintegration when delivered to patients, as the 
drug is entrapped in the polymeric network at the 
particulate level (Figure 1).   
Figure 1, Cross-sectional view of typical hydrophilic matrix tablet 
Numerous swellable, carbohydrate-based polymers are 
available, allowing flexibility for the needs of an 
individual formulation to achieve specific goals in drug 
therapy [8]. 
3. Cellulose ether-based hydrophilic 
matrices 
Among the swellable polymers usually used to develop 
these hydrophilic matrices, cellulose ethers, specifically 
methylcellulose (MC) and hypromellose (hydroxypropyl 
methylcellulose, HPMC), have provoked extensive 
interest [6]. Their widespread acceptance can be attributed 
to good compression properties, adequate swelling 
characteristics which allow the matrix tablet to develop an 
external gel layer on the surface of matrix tablet, non-toxic 
nature, availability in different grades, ability to give pH 
independent drug release profiles, anti-static properties 
and amenability to high levels of drug loading [7,8].  
4.  Mechanism of swelling, erosion and drug 
release  
Polymer swelling, drug dissolution and matrix erosion 
are the phenomena that determine the mechanism of drug 
release from hydrophilic matrix tablets, either on a 
macroscopic or molecular level [11]. When drug loaded 
swellable cellulose ethers  based hydrophilic matrices are 
exposed to dissolution fluid, steep water concentration 
gradients are formed between the dissolution fluid and the 
outermost surface of matrix tablet. This results in water 
imbibition into the polymer matrix network. To describe 
this process adequately, it is important to consider the 
exact geometry of the matrix tablet, as in the case of 
cylinders, both axial and radial directions of mass 
transport can be manifested which have a significant 
dependence of the water diffusion coefficient and the 
matrix swelling [12,13].When dry matrix tablets are 
introduced into the liquid system, the diffusion coefficient 
tends to be very low, whereas in highly swollen gels, it is 
of the same magnitude as pure water. So, the liquid acts as 
a plasticizer and the glass transition temperature (Tg) 
reduces from somewhere between 154 – 184 ºC to around 
the system temperature, 37 ºC [14]. Once the Tg equals the 
temperature of the system, the polymer chains start to 
relax and eventually disentangle increasing the molecular 
surface area [6]. This phenomenon of polymer chain 
relaxation is termed ‘swelling’ and the continuous inward 
ingression of liquid breaks the hydrogen bonds formed 
during tablet compaction and can lead to the development 
of new hydrogen bonds accommodating water molecules 
[15]. Therefore, the reduction in Tg and formation of new 
hydrogen bonds results in the swelling of polymer chains. 
As a consequence, a thick gelatinous layer appears on the 
surface of matrix tablets, commonly known as a gel layer, 
as MC/HPMC pass from the amorphous glassy state to the 
rubbery state ([8, 16-19]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The development of the gel layer actually divides the 
matrix tablet into three different distinguishable regions. 
The highly swollen outer region (erosion front) has the 
highest amount of water molecules but it is mechanically 
weak. However, it acts as a diffusion barrier preventing 
water penetration into the other two regions. The middle 
region (dissolution front) is moderately swollen and is 
relatively stronger than the outer one. The core of the 
matrix tablet which actually forms the innermost region 
(swelling front), remains essentially dry and holds its 
glassy state for a longer period of time [6,20]. Moreover, 
there is evidence that a fourth front (penetration front) is 
also present, between the swelling and dissolution fronts, 
adding further complexity to the system [21]. A schematic 
illustration of the different fronts which develop due to 
liquid penetration is shown in Figure 2.   
 
  The gel layer grows over time as more water penetrates 
into the matrix tablet. The polymer chains present on the 
surface of matrix tablet hydrate quickly compared to those 
located inside the core and contact with the liquid causes 
chain relaxation (swelling) which initiates erosion of the 
matrix. Instantaneously, the outermost layer becomes fully 
hydrated and starts to relax, leading to the 
disentanglement of polymeric chains [22]. Consequently, 
matrices start to dissolve from their surface, as water 
continuously permeates towards the core [23]. The relative 
rates of liquid uptake and erosion of a polymer matrix play 
a critical role in controlling the rate of drug release. The 
swelling, matrix erosion, drug release mechanism and rate 
are dependent on the concentration, degree of substitution 
and polymer chain length of HPMC being used in the 
hydrophilic matrices [24,25]. HPMC has the potential to 
hydrate quickly enough to form a gel layer before the drug 
entrapped in the tablet matrix can dissolve. 
There are two processes involved during the dissolution 
of hydrophilic matrix tablets, by which polymer erosion 
from the hydrophilic matrices takes place. Firstly, the 
disentanglement of individual polymer chains at the 
surface of matrix tablets and secondly their subsequent 
transport  to the surrounding  bulk  solution. The  physical  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2, Mechanism of drug release from hydrophilic matrix tablet 
 entanglement of the polymer chains precludes polymer 
dissolution, but polymer present at the outermost surface 
is diluted by the bulk dissolution medium over time to a 
point when the polymeric network no longer has structural 
integrity. This eventually leads to polymer 
disentanglement and the matrix tablet starts to disappear 
[4,6,13,17,26]. Both MC and HPMC are water soluble 
and, as the water penetrates into the hydrophilic matrix, 
the polymer chains become hydrated and these eventually 
start to disentangle from the matrix because MC and 
HPMC contain linear hydrophilic polymeric chains which 
do not chemically cross-link but instead form a gelatinous 
layer on the surface of the tablets that is vulnerable to 
matrix erosion. At high polymer concentrations, the linear 
polymer chains entangle to form what may be considered 
a physically cross-linked structure, which eventually 
erodes, resulting in the liberation of polymer and drug 
molecules [24]. However, the rate of polymer erosion is 
dependent on the viscosity of the MC/HPMC grade being 
used in the formulation. Tablets fabricated using a high 
molecular weight and viscosity grade MC/HPMC show 
more resistance to polymer erosion than the low molecular 
weight and low viscosity grades [4,27]. 
Figure 3 illustrates a general drug release mechanism 
on the basis of solubility of incorporated drugs. Release is 
controlled by diffusion through, and erosion of, the gel 
layer and any drug present on the surface of the matrix 
tablet is quickly released. This is followed by expansion 
of the gel layer as water permeates into the tablet, 
increasing the thickness of the gel layer [28,29]. If a well-
defined gel layer is formed, the rate of drug release is 
reduced and becomes dependent on the rate at which the 
drug molecules diffuse through the gel, as well as the rate 
at which the barrier layer is mechanically removed by 
attrition and disentanglement of the matrix. In most cases, 
both diffusion and erosion occur simultaneously [30-34] 
Highly water soluble drugs diffuse through the gel layer 
before the matrix erodes, but it is suggested that the 
presence of poorly soluble drugs can increase matrix 
erosion by imperilling the integrity of the gel layer 
[33,34]. So, the solubility of entrapped drugs is another 
key factor in determining the drug release behaviour from 
hydrophilic matrices. Mechanistically, both diffusion and 
erosion will be contributing factors in controlling drug 
release from a hydrophilic matrix tablet. In practical 
terms, however, one process will often play a dominant 
role over the other depending on the HPMC level and 
solubility of other matrix tablet contents [35]. 
5. Factors affecting drug release 
Although the fabrication of compressed hydrophilic 
matrices may be simple, it becomes very complex and 
challenging when it comes to explaining the mechanism of 
drug release from these polymeric devices. The 
physicochemical properties of MC/HPMC and 
incorporated drug significantly impact the swelling, 
erosion and drug release. In this section, the principal 
factors that can affect swelling, erosion and drug release 
will be discussed; however, a summary of all the major 
contributing factors is presented in Table 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3, Release mechanism of water soluble and poorly water soluble 
drugs from hydrophilic matrix tablet 
5.1. Effect of concentration  
Commonly, it is noticed that regardless of the 
physicochemical properties of hydrophilic polymer, the 
drug release rate decreases with an increase in the levels 
of polymer in a hydrophilic matrix tablet. Reza et al. 
(2003) [36] reported that higher levels of polymer 
correspond to a lower porosity of the matrix tablet and 
slower drug release rates can be achieved. Moreover, 
Ebube et al. (2004) [37] investigated the effect of polymer 
levels on the release of acetaminophen and found an 
increase in the percentage of polymer (3.5% to 19.2%) in 
the matrix tablet led to a decrease in the drug release rate. 
The results of these experiments are in complete 
agreement with the findings of Mitchell et al. (1993) [24], 
who concluded that a greater degree of physical cross-
linking of polymer chains is evident when the amount of 
HPMC has been increased. This in turn increases the 
tortuosity of release pathway from the matrix tablets and 
essentially corresponds to slower drug release. The  first 5 
min contact between the matrix tablet and aqueous fluids 
is a very important time for the development of the gel 
layer on the surface of matrix tablet [38,39]. After such 
times, if the structure has not formed, the matrix may 
erode too quickly and lead to premature drug release. 
Higher polymer content in a matrix tablet results in the 
formation of a stronger gel; at low polymer levels the gel 
does not form quickly. As hypromellose content is 
increased, the resulting gelatinous diffusion layer becomes 
stronger and more resistant to diffusion and erosion [40]. 
Recently, Jain et al. (2014) [41] concluded that the higher 
levels of HPMC in a matrix tablet exhibit slower erosion 
and drug release rate. These conclusions are in complete 
accordance with the findings of Ghori et al. (2014) [34], 
who reported that the increase in the HPMC concentration 
(20% to 80 %) in a matrix tablet tends to decrease the rate 
drug release, regardless of drug solubility.    
However, there is a difference of opinion, as some 
authors do not agree with this notion, as in the case of 
[23]. In their studies, these authors prepared the 
hydrophilic matrices incorporating a highly water soluble 
drug, tramadol, and failed to observe significant changes 
in the release profile with changes in the polymer 
concentration. In formulations of drugs that are highly 
soluble in water, it is usual to find that, above a certain 
percentage of polymer, the release rate does not decrease.  
It was reported that once a particular polymer level is 
reached, the effects from characteristics such as viscosity, 
burst effect and particle size are less evident. A polymer 
content of 30% – 40% appears to be the level at which 
similar drug-release profiles are obtained from differing 
grades of hypromellose (2208, 2906, and 2910) [39]. 
However, Campos-Aldrete and Villafuerte-Robles (1997) 
[38] reported that the HPMC concentrations higher than 
20% can become the overriding factor and the effect of 
viscosity and particle size do not cause any significant 
changes in the drug release profiles. Moreover, the 
conclusions of Heng et al. (2001) [42] are in complete 
accordance with aforementioned studies, and that the 
increase in HPMC concentration can significantly 
suppress the impact of particle size.  
5.2. Effect of particle size  
Over the years, the effect of the particle size of the 
polymer on drug release has been studied in depth by 
different authors [38, 43-46]. A general observation can be 
drawn from these studies that the particle size of the 
polymer is not as decisive as expected. However, narrower 
particle size distribution of polymer in a matrix system 
initiates the prompt development of the gel layer on the 
surface of matrix tablet. Hydrophilic matrices formulated 
with polymer particles sizes larger than 200 μm 
disintegrate before the development of the so-called 
surface gel layer, while those formulated with particle 
sizes smaller than 150 μm can form the gel layer rapidly, 
preventing the disintegration of the system and lead to 
prolonged drug release profiles [47]. Mitchell et al. (1993) 
[24] reported that the polymer particles tend to dissolve 
slowly and failed to provide adequate controlled drug 
release. The use of larger sized hypromellose K15M 
particles (> 355 µm) left much larger pores on the surface 
of matrices that essentially make the gel layer structure 
unstable and lead to rapid drug release. Some authors have 
proposed that the effect of MC/HPMC particle size can be 
minimised with high concentrations of polymers, as 
described in the earlier section, 4.5.1. Heng et al. (2001) 
[42] carried out experiments to elucidate the impact of 
particle size on drug release profiles. It was revealed that 
the HPMC K15M matrices, with a mean particle size 
smaller than 113 μm, release drug through a combination 
of erosion and diffusion mechanisms. However, for matrix 
tablets having a HPMC particle size of greater than 113 
μm there was rapid drug release behaviour and the release 
mechanism was considered to be more erosion-based. 
Furthermore, Miranda et al. (2007) [48] reported on the 
relationship between particle size of matrix components 
and their percolation threshold. It was concluded that the 
larger polymer particle sizes were less effective in the 
formation of a homogeneous gel layer.  
5.3. Effect of substitution  
Different polymer properties have been reported to be 
responsible for the rate of polymer hydration, including 
substitution type. It was initially proposed that cellulose 
ethers of different substitution levels hydrate at different 
rates and this factor may be used to optimise the 
formulation of sustained release matrices (Alderman, 
1984). However, using a combination of differential 
scanning calorimetry (DSC) and dissolution studies 
showed that the differences in release rates for HPMCs 
[24] with different substitution levels are not due to 
differences in hydration rate. Further studies using 
thermo-mechanical analysis [49] indicated that the gel 
layer thickness (which will affect the diffusional path 
length) is similar in HPMCs of different substitution type. 
The type of the substituent determines the hydration rate 
of the polymer and can significantly affect the hydration 
rate and drug release. The drug release is dependent on the 
substitution type if the polymer level is kept low, so that 
the polymer concentration is not the overriding factor in 
controlling the swelling, erosion and drug release 
behaviour of hydrophilic matrices [18,50]. The change in 
the substitution levels impacts the polymer relaxation in 
tablet matrices; it was confirmed that different substitution 
levels gave rise to different water mobility, leading to 
differing drug-release characteristics [51]. Furthermore, 
McCrystal et al. (1999) [52] confirmed that the amount of 
water that attaches to the polymer and the amount of 
tightly bound water significantly depend on the degree of 
substitution. The substituents of a polymer side chain alter 
its polarity and melting point. For example, substitutions 
of the side-chain groups by more polar groups result in a 
reduction in the crystallinity of the polymer, which is 
reflected in a decrease in its melting point. This affects the 
solubility of the polymer in water. In general, the aqueous 
solubility of a polymer can be said to be related to its 
ability to establish hydrogen bridges between the 
hydrogen atoms of the water and those of the oxygen 
present in the side chain and the substituents of the 
polymer [53]. In the particular case of matrix systems, the 
type of substitution not only influences the solubility of 
the polymer in water, but also the gel strength, and the 
swelling and erosion of the polymer. In the case of 
HPMC, the rate of swelling depends on the side-chain 
substituents, such that the higher the number of hydroxyl 
groups, the faster the hydration [54-57]. Moreover, 
Escudero et al. (2010) [57] studied the influence of 
replacement of the HPMC chain on the release of 
theophylline contained in mixtures of a swelling polymer 
with an inert one. Three different types of substitution 
based on methoxyl and hydroxyl groups were tested; 
E4M, K4M and F4M, and the HPMC F4M resulted in 
slower drug release rates because it had the largest number 
of hydrophobic substituents (methoxyl). For the ratio, 
inert polymer/swelling polymer 75:25, where the 
characteristics of viscosity and substitution of the HPMC 
were less important than the properties of the inert 
polymer, the mixtures made with HPMC F4M and E4M 
allowed a more homogeneous gel structure and easier 
modulation of drug release rate. 
5.4. Effect of viscosity (molecular size/chain length) 
The viscosity of MC/ HPMC is considered to be another 
important parameter that controls and determines the 
mechanism of release. The viscosity of a polymer in 
solution very much depends on the chemical structure of 
the polymer, its molecular weight and its interaction with 
the solvent. Various authors have studied the impact of 
MC/HPMC viscosity on drug release from hydrophilic 
matrices. It can be concluded from these studies that the 
higher the viscosity of a polymer, the faster the swelling 
of its side chains, forming a very strong gel, which 
decreases the drug release rate. Moreover, various studies 
have reported a decline in the rate of drug release with 
increase in the polymer viscosity [58-60].  
A study carried out by Wan et al. (1991) [61] proposed 
that an increase in viscosity of HPMC tends to increase 
the swelling and drug release rates. It can be attributed to 
the fact that the pores of high-viscosity hypromellose 
block up quickly and inhibit further liquid uptake. This in 
turn leads to the formation of a turbid gel, which resists 
dilution and erosion, subsequently resulting in slower drug 
diffusion and release rates [62].  
Furthermore, it has been demonstrated by Campos-
Aldrete and Villafuerte-Robles (1997) [38] that in the case 
of HPMC, increases in the viscosity of the polymer lead to 
slower drug release rates as long as the percentages of 
polymer do not surpass 20%. Studies addressing swelling 
and erosion carried out by Ravi et al. (2008) [63]  have 
shown that the percentages of swelling and erosion are 
completely dependent on the viscosity of the polymer and 
the percentage of swelling increases as the viscosity of  
HPMC increases, however, the percentage of erosion 
decreases when the viscosity of the polymer increases.  
5.5. Effect of drug solubility 
Drug solubility is a very important factor as high or low 
solubility can significantly affect the gel characteristics 
and drug release [62, 64, 65]. Ford et al. (1985) [66] 
studied the release of both water soluble (promethazine 
hydrochloride, aminophylline and propranolol 
hydrochloride) and poorly soluble (indomethacin) drugs 
from HPMC matrix systems. For indomethacin, both the 
viscosity grade of HPMC and the particle size of the drug 
were reported to contribute more to controlling the drug 
release than was the case for water soluble drugs. This 
was primarily due to the dominant erosion mechanism of 
drug release in the case of poorly soluble drugs. High 
concentrations of insoluble drugs and excipients may 
cause non-uniform swelling of the hydrophilic matrix 
tablet. However, careful tailoring of the concentrations of 
insoluble drug and polymer in a system can be used to 
slow the dissolution rate of the insoluble drug [67]. It has 
been suggested that highly-soluble drugs can be released 
by diffusing through the gel matrices and this is 
considered to be the main pathway for their release. 
However, drug release also occurs through erosion of the 
gel matrix. It is said that highly soluble drugs can also act 
as pore formers with the formation of micro-cavities, 
rendering the gel structure more porous and weaker, hence 
leading to increased drug release rates. Poorly soluble 
drugs, however, are released predominantly by erosion of 
the gel matrix, as the drug particles translocate and their 
presence compromises the structural integrity of the gel 
layer present on the surface of the matrix tablet, leading to 
drug release through matrix erosion [33,68]. Several 
authors have studied whether the incorporation of highly 
water-soluble drugs into matrix systems with hydrophilic 
or hydrophobic polymers affects the drug release rate. 
Tramadol was formulated with HPMC or hydrogenated 
castor oil (HCO) and it was easier to modulate the release 
rate of the highly water-soluble drug from HMPC matrices 
than in those made of HCO [23]. Recently, Ghori et al. 
(2014) [34] reported similar findings, i.e., that the poorly 
soluble drug was released predominately through erosion 
while the water soluble drug was released via a diffusion 
mechanism. Furthermore, Ghori et al. (2014) [34] 
demonstrated that the values of the drug diffusion co-
efficient (for a poorly soluble model drug) of the 
Korsmeyer and Peppas model (n) are linearly related to 
the erosion rate of matrices, endorsing the view that 
poorly water soluble drugs are released mainly through an 
erosion mechanism. 
6. Conclusions 
Hydrophilic matrices have distinct advantages which 
make them interesting candidate for oral controlled drug 
delivery. This review has elaborated the factors related to 
drug release mechanism from hydrophilic matrices. 
Moreover, various physicochemical attributes associated 
with polymers have significant impact on the performance 
and functionalities of hydrophilic matrices. This critical 
information can be used in the development of hydrophilic 
matrices.  
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